首页> 美国卫生研究院文献>Cancer Management and Research >Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance Epidemiology and End Results (SEER) Analysis
【2h】

Comparison of the 7th and 8th edition of American Joint Committee on Cancer (AJCC) staging systems for breast cancer patients: a Surveillance Epidemiology and End Results (SEER) Analysis

机译:美国乳腺癌联合委员会(AJCC)分期系统的第7版和第8版比较:监测流行病学和最终结果(SEER)分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

BackgroundThe 8th edition of the American Joint Committee on Cancer (AJCC) staging system for breast cancer has incorporated tumor grade, estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 status as staging biologic factors reflecting prognosis. The purpose of this study was to compare the 7th and 8th edition of AJCC staging system for prognostic impact.
机译:背景美国乳腺癌联合分期系统(AJCC)的第8版将肿瘤等级,雌激素受体,孕激素受体和人表皮生长因子受体2的状态纳入了反映预后的分期生物学因素。这项研究的目的是比较AJCC分期系统的第7版和第8版对预后的影响。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号